Cart
sales@molnova.com
Olsalazine
CAS No. 15722-48-2
Olsalazine( Dipentium | Salicylic acid )
Catalog No. M23683 CAS No. 15722-48-2
Olsalazine, an anti-inflammatory drug, is used in the treatment of inflammatory bowel disease. It is also a novel DNA hypomethylating agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 76 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 161 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOlsalazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOlsalazine, an anti-inflammatory drug, is used in the treatment of inflammatory bowel disease. It is also a novel DNA hypomethylating agent.
-
DescriptionOlsalazine, an anti-inflammatory drug, is used in the treatment of inflammatory bowel disease. It is also a novel DNA hypomethylating agent.
-
In Vitro——
-
In Vivo——
-
SynonymsDipentium | Salicylic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15722-48-2
-
Formula Weight302.24
-
Molecular FormulaC14H10N2O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Kawy OA, Ibrahim IT, Farah K. Technetium-99?m labeling and evaluation of olsalazine: a novel agent for ulcerative colitis imaging. J Labelled Comp Radiopharm. 2015 Jun 30;58(8):336-41. doi: 10.1002/jlcr.3306. Epub 2015 Jun 1. PubMed PMID: 26031480.
molnova catalog
related products
-
Bruceantarin
Bruceantarin is a potent antineoplastic agent. Bruceantarin can be used for leukemia and breast cancer research.
-
Ac-Phe-NH2
Ac-Phe-NH2 is a non-competitive inhibitor of polyubiquitin chain elongation at Ki value of 8 ± 1.2 mM.
-
MW01-2-151SRM
MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
